Alpha-methyldopa is one of the most widely used antihypertensive drugs during pregnancy. In spite of its known potential hepatotoxicity, there have been only a few reports describing hepatotoxicity with the use of this drug during pregnancy. We report here a new case of a 36-year-old pregnant hypertensive woman presented with acute hepatitis related to the use of alpha-methyldopa.
Nasser, M., Mahmoud, A., Ahmed, E. S., & Reham, S. (2018). Alpha-Methyldopa-induced hepatitis during pregnancy. Medical Journal of Viral Hepatitis, 2.2(2), 15-16. doi: 10.21608/mjvh.2018.55736
MLA
Mousa Nasser; Abdel-Aziz Mahmoud; El Shabrawi Ahmed; Soliman Reham. "Alpha-Methyldopa-induced hepatitis during pregnancy", Medical Journal of Viral Hepatitis, 2.2, 2, 2018, 15-16. doi: 10.21608/mjvh.2018.55736
HARVARD
Nasser, M., Mahmoud, A., Ahmed, E. S., Reham, S. (2018). 'Alpha-Methyldopa-induced hepatitis during pregnancy', Medical Journal of Viral Hepatitis, 2.2(2), pp. 15-16. doi: 10.21608/mjvh.2018.55736
VANCOUVER
Nasser, M., Mahmoud, A., Ahmed, E. S., Reham, S. Alpha-Methyldopa-induced hepatitis during pregnancy. Medical Journal of Viral Hepatitis, 2018; 2.2(2): 15-16. doi: 10.21608/mjvh.2018.55736
)
View on SCiNiTO